However, the gene‐level integrated analysis revealed heterogeneity in expression, copy number variation and methylation status of MDM4, RRAGC, HERC2, BIRC3 and TSC2 genes within and across individual tumours (supplementary Figure S7B), suggesting that they may not be ideal biomarkers for PDAC. This evidence concerns the gene HERC2 and neoplasm.